Dual Targeting of Slamf-7 and CD38 in Mulitple Myeloma (MM): A Phase II Study of Isatuximab, Elotuzumab, Pomalidomide and Dexamethasone (Isa-EloPD) in Relapsed and/or Refractory MM (RRMM)Binod Dhakal,Meera Mohan, Ravi Narra,Katie Palen,Aniko Szabo,Tyce Kearl, Gayathri Ravi,Susan Bal,Bryon D. Johnson,Marcelo Pasquini, Anita D'Souza,Parameswaran N. Hari,Luciano CostaBLOOD（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
